Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist

Hugh S. Taylor(Yale University), Kristof Chwalisż(AbbVie (United States)), Jan Kotarski(Medical University of Lublin), Nicholas Leyland(McMaster University), W. Rachel Duan(AbbVie (United States)), Linda C. Giudice(University of California, San Francisco), John C. Gallagher(University of Cincinnati), Bruce A. Lessey(Atrium Health Wake Forest Baptist), Brittany Schwefel(AbbVie (United States)), J.P. Rowan(AbbVie (United States)), James A. Simon(George Washington University), Juki Ng(AbbVie (United States)), Nelson B. Watts(Mercy Health), James W. Thomas(National Institutes of Health), Bruce R. Carr(University of Florida), David F. Archer(Eastern Virginia Medical School), Neil P. Johnson(The University of Adelaide), Eric S. Surrey(Colorado Center for Reproductive Medicine), Rita I. Jain(AbbVie (United States)), Maurício Simões Abrão(Beneficência Portuguesa de São Paulo), W. Paul Dmowski(Creighton University), Michael P. Diamond(Augusta University)
New England Journal of Medicine
May 19, 2017
Cited by 492


Related Papers